Berlin
Helios Klinikum Berlin-Buch - Klinik für Hämatologie und Zelltherapie
Schwanebecker Chaussee 50
D-13125 Berlin
D-13125 Berlin
Leitung: Prof. Dr. med. Bertram Glaß
Studien
-
INTEGRATE ATMP
-
Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma (ZUMA-23)
-
Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma (ZUMA-22)
-
Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients (DALY 2-EU)
-
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Studien
-
INTEGRATE ATMP
-
Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma (ZUMA-23)
-
Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma (ZUMA-22)
-
Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients (DALY 2-EU)
-
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells